China, America and pay inject drama into AstraZeneca’s AGM

Britain’s largest company, AstraZeneca, is facing scrutiny over the annual bonus of its CEO, Pascal Soriot, who has been the best-paid FTSE 100 chief executive for the past five years. However, this year’s virtual general meeting is also overshadowed by investigations in China regarding import and data breaches, as well as controversy over the cancellation of a £450m expansion of its vaccine site in Speke, near Liverpool, due to a lack of government support.

Full Article